JO
CRVO icon

John Overdeck’s CervoMed CRVO Stock Holding History

John Overdeck’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,512
Closed -$98.8K – 4636
2025
Q4 		$98.8K Sell
12,512
-4,596
-27% -$36.9K ﹤0.01% 3857
2025
Q3 		$138K Buy
+17,108
New +$147K ﹤0.01% 3428
2021
Q1 		– Sell
-1,418
Closed -$85K – 3885
2020
Q4 		$85K Buy
+1,418
New +$83.1K ﹤0.01% 3221
2019
Q1 		– Sell
-429
Closed -$64K – 3092
2018
Q4 		$64K Buy
+429
New +$146K ﹤0.01% 2852

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Overdeck's CRVO Position: Q1 2026 in Review

John Overdeck sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 12,512 shares — an estimated $98.8K sold.

John Overdeck first reported a position in CRVO in Q4 2018 and held it in 4 quarters. The position peaked at $138K in Q3 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • John Overdeck reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 12,512 CervoMed shares in Q1 2026, an estimated $98.8K.
  • John Overdeck first reported a position in CervoMed in Q4 2018 and held it in 4 quarters.
  • John Overdeck's CervoMed position peaked at $138K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.